Awareness of atrial fibrogenesis and natriuretic peptide release.
作者信息
Meijers W C F W, Jaarsma T, van Veldhuisen D J, Hoekstra T, de Boer R A
机构信息
Department of Cardiology, University Medical Centre, University of Groningen, Groningen, The Netherlands.
Faculty of Health Sciences, Linköping University, Linköping, Sweden.
出版信息
Neth Heart J. 2017 Mar;25(3):225-226. doi: 10.1007/s12471-017-0955-6.
Abstract
摘要
相似文献
1
Awareness of atrial fibrogenesis and natriuretic peptide release.
Neth Heart J. 2017 Mar;25(3):225-226. doi: 10.1007/s12471-017-0955-6.
2
Hypoxia induces release of atrial natriuretic peptide in rat atrial tissue: a role for this peptide during low oxygen stress.
Naunyn Schmiedebergs Arch Pharmacol. 1994 Aug;350(2):189-93. doi: 10.1007/BF00241095.
3
Effects of prolonged infusions of atrial natriuretic peptide and isoproterenol on the mechanical and endocrine function of isolated atria.
Cardioscience. 1990 Sep;1(3):217-23.
4
Effect of atrial natriuretic peptide on catecholamine release from human pheochromocytoma.心房利钠肽对人嗜铬细胞瘤儿茶酚胺释放的影响。
Acta Endocrinol (Copenh). 1989 Jan;120(1):107-12. doi: 10.1530/acta.0.1200107.
5
Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea.鼻腔持续气道正压通气治疗对阻塞性睡眠呼吸暂停患者睡眠期间心房利钠肽和精氨酸加压素释放的影响。
Clin Sci (Lond). 1991 May;80(5):443-9. doi: 10.1042/cs0800443.
6
Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.心房利钠肽（ANP）通过ANP（A）受体抑制其自身分泌：实验性高血压中的效应改变。
Endocrinology. 1997 May;138(5):1893-902. doi: 10.1210/endo.138.5.5120.
7
Role of atrial natriuretic peptide on calcium channel mechanisms involved in catecholamine release from bovine adrenal medulla.心房利钠肽对牛肾上腺髓质儿茶酚胺释放所涉及的钙通道机制的作用。
Arch Int Pharmacodyn Ther. 1992 Mar-Apr;316:105-13.
8
The pathway of atrial natriuretic peptide release--from cell to plasma.心房利钠肽释放的途径——从细胞到血浆。
Cardioscience. 1991 Dec;2(4):263-72.
9
Atrial natriuretic peptide in brain and pituitary gland.脑和垂体中的心房利钠肽。
Physiol Rev. 1997 Apr;77(2):465-515. doi: 10.1152/physrev.1997.77.2.465.
10
Atrial natriuretic peptide inhibits evoked catecholamine release by altering sensitivity to calcium.
J Pharmacol Exp Ther. 1997 Nov;283(2):426-33.
本文引用的文献
1
Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides.射血分数保留且利钠肽水平低的心力衰竭患者。
Neth Heart J. 2016 Apr;24(4):287-95. doi: 10.1007/s12471-016-0816-8.
2
The fibrosis-cell death axis in heart failure.心力衰竭中的纤维化-细胞死亡轴
Heart Fail Rev. 2016 Mar;21(2):199-211. doi: 10.1007/s10741-016-9536-9.
3
Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH.心力衰竭的生物标志物和低风险。COACH 和 TRIUMPH 研究的数据。
Eur J Heart Fail. 2015 Dec;17(12):1271-82. doi: 10.1002/ejhf.407. Epub 2015 Oct 14.
4
Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials.血浆半乳糖凝集素-3 水平升高与心力衰竭近期再住院相关：3 项临床试验的汇总分析。
Am Heart J. 2014 Jun;167(6):853-60.e4. doi: 10.1016/j.ahj.2014.02.011. Epub 2014 Mar 5.
5
Stiff left atrial syndrome following left atrial appendage resection and multiple ablations for atrial fibrillation.左心耳切除及多次房颤消融术后的僵硬左心房综合征
Heart. 2013 Apr;99(7):508. doi: 10.1136/heartjnl-2012-303171. Epub 2012 Dec 12.
6
Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors.左房僵硬综合征在房颤导管消融术后：临床特征、患病率和预测因素。
Heart Rhythm. 2011 Sep;8(9):1364-71. doi: 10.1016/j.hrthm.2011.02.026. Epub 2011 Feb 23.
7
Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation: role of duration of atrial fibrillation.心力衰竭合并慢性心房颤动患者的心房利钠肽：心房颤动持续时间的作用
Am Heart J. 1998 Feb;135(2 Pt 1):242-4. doi: 10.1016/s0002-8703(98)70088-2.
Zotero 插件